T1	Participants 58 124	patients with type 2 diabetes mellitus and coronary artery disease
T2	Participants 334 385	patients receiving dual antiplatelet therapy (DAPT)
T3	Participants 834 896	DM patients with stable coronary artery disease receiving DAPT
T4	Participants 2107 2162	DM patients with coronary artery disease receiving DAPT
